 | Short Interest in Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Declines By 7.8%
www.americanbankingnews.com - July 9 at 3:09 AM |
| Insider Selling: Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Insider Sells 8,185 Shares of Stock
www.americanbankingnews.com - July 7 at 4:14 AM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) COO James B. Weissman Sells 4,360 Shares
www.marketbeat.com - July 7 at 4:14 AM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $76.04 Million
www.americanbankingnews.com - July 5 at 3:56 AM |
| Analysts Anticipate Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Will Post Earnings of $0.21 Per Share
www.americanbankingnews.com - July 3 at 3:40 PM |
 | Dicerna Pharmaceuticals (NASDAQ:DRNA) Stock Rating Lowered by ValuEngine
www.marketbeat.com - July 2 at 1:40 AM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 30 at 2:04 PM |
| Bob D. Brown Sells 9,670 Shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Stock
www.marketbeat.com - June 23 at 8:42 PM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Short Interest Update
www.americanbankingnews.com - June 22 at 1:51 AM |
 | Dicerna nabs Rare Pediatric Disease tag for nedosiran for primary hyperoxaluria
seekingalpha.com - June 18 at 1:05 PM |
|
 | Dicerna Receives Rare Pediatric Disease Designation From U.S. Food and Drug Administration for Nedosiran for Treatment of Primary Hyperoxaluria
finance.yahoo.com - June 18 at 8:05 AM |
| Dicerna Pharmaceuticals (NASDAQ:DRNA) Receives Buy Rating from B. Riley
www.americanbankingnews.com - June 16 at 8:03 AM |
| Hedge Funds Aren’t Crazy About Dicerna Pharmaceuticals Inc (DRNA) Anymore
finance.yahoo.com - June 15 at 12:29 PM |
| Dicerna to Participate in Jefferies Virtual Global Healthcare Conference
finance.yahoo.com - May 26 at 6:40 PM |
 | DRNA Dicerna Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - May 23 at 11:57 PM |
| Dicerna Pharmaceuticals (DRNA) Presents At UBS Global Healthcare Conference - Slideshow
seekingalpha.com - May 20 at 5:54 PM |
| Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Analysts Are Way More Bearish Than They Used To Be
finance.yahoo.com - May 18 at 8:40 AM |
| Dicerna to Present at Upcoming May Investor Conferences
finance.yahoo.com - May 12 at 6:27 PM |
| Were Hedge Funds Right About Dicerna Pharmaceuticals Inc (DRNA)?
finance.yahoo.com - May 10 at 11:43 PM |
| Dicerna Pharmaceuticals, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
finance.yahoo.com - May 10 at 1:42 PM |
| Dicerna Pharmaceuticals, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
finance.yahoo.com - May 10 at 1:42 PM |
| Dicerna Pharmaceuticals Inc (DRNA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 9 at 8:42 PM |
| Edited Transcript of DRNA earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 8:54 PM |
| The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
finance.yahoo.com - May 8 at 3:53 PM |
| Dicerna Pharmaceuticals (NASDAQ:DRNA) Receives "Buy" Rating from Chardan Capital
www.marketbeat.com - May 8 at 7:55 AM |
| Dicerna Pharmaceuticals' (DRNA) "Buy" Rating Reiterated at HC Wainwright
www.marketbeat.com - May 8 at 7:55 AM |
| Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 7 at 9:50 PM |
| Dicerna Pharmaceuticals EPS misses by $0.58, misses on revenue
seekingalpha.com - May 7 at 4:50 PM |
| Dicerna Announces Appointment of Douglas Pagán as Chief Financial Officer
finance.yahoo.com - May 7 at 4:50 PM |
| Dicerna Announces First Quarter 2020 Financial Results and Provides a Business Update
finance.yahoo.com - May 7 at 4:50 PM |
|
| Dicerna to Report First Quarter 2020 Financial Results on May 7, 2020
finance.yahoo.com - April 30 at 9:57 PM |
| We're Not Worried About Dicerna Pharmaceuticals's (NASDAQ:DRNA) Cash Burn
finance.yahoo.com - April 29 at 9:53 AM |
| We're Not Worried About Dicerna Pharmaceuticals's (NASDAQ:DRNA) Cash Burn
finance.yahoo.com - April 29 at 9:53 AM |
| Diving Into Dicerna Pharmaceuticals
seekingalpha.com - April 14 at 3:32 PM |
| Biotech vet Gilman's startup earns $190M-plus in Roche deal
finance.yahoo.com - April 8 at 7:26 AM |
| Dicerna Provides Initial Observations From PHYOX™3 Trial of Nedosiran for Treatment of Primary Hyperoxaluria and an Update on Data Presentation Plan
finance.yahoo.com - March 31 at 11:21 AM |
| Dicerna Addresses Business Continuity in Response to COVID-19 Pandemic
finance.yahoo.com - March 26 at 5:16 PM |
| Stocks Flashing Renewed Technical Strength: Dicerna Pharmaceuticals
finance.yahoo.com - March 23 at 6:52 PM |
| Dicerna Pharmaceuticals, Inc. Common Stock (DRNA) Insider Activity | Nasdaq
www.nasdaq.com - March 21 at 7:36 AM |
| Dicerna's DCR-A1AT an Orphan Drug in U.S. for alpha-1 antitrypsin deficiency
seekingalpha.com - March 19 at 1:02 PM |
| Dicerna Pharmaceuticals (DRNA) Presents At Cowen and Comapny 40th Annual Health Care Conference - Slideshow
seekingalpha.com - March 17 at 8:19 AM |
| Edited Transcript of DRNA earnings conference call or presentation 27-Feb-20 9:30pm GMT
finance.yahoo.com - March 9 at 5:25 PM |
| Earnings Beat: Dicerna Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
finance.yahoo.com - February 29 at 1:10 PM |
| Dicerna Pharmaceuticals EPS misses by $0.45, misses on revenue
seekingalpha.com - February 27 at 5:58 PM |
| Dicerna™ Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - February 27 at 5:58 PM |
| Dicerna™ to Report Fourth Quarter and Full Year 2019 Financial Results on Feb. 27, 2020
finance.yahoo.com - February 20 at 10:56 PM |
| Dicerna™ to Present at Upcoming Investor Conferences
finance.yahoo.com - February 18 at 5:49 PM |
| Dicerna™ Appoints Stephen Doberstein, Ph.D., to Board of Directors
finance.yahoo.com - February 10 at 8:10 AM |
| Dicerna™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - February 3 at 7:09 PM |
| Dicerna™ Receives Orphan Drug Designation From European Commission for DCR-A1AT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency
finance.yahoo.com - December 17 at 8:19 AM |
